One-two punch of palbociclib and paclitaxel shows promise against advanced breast can
 

Combining the new breast cancer drug palbociclib with paclitaxel (Taxol) shrank tumors in nearly half of patient with estrogen-receptor (ER) positive breast cancer, according to new research from the...

More...